GIT2 deficiency attenuates concanavalin A-induced hepatitis in mice

FEBS Open Bio

Volumn 5, Issue , 2015, Pages 688-704

  Hao, Yu E ^a,b   He, Dong Fang ^b,c   Yin, Rong Hua ^b   Chen, Hui ^b   Wang, Jian ^b   Wang, Shao Xia ^b   Zhan, Yi Qun ^b   Ge, Chang Hui ^b   Li, Chang Yan ^b   Yu, Miao ^b   Yang, Xiao Ming ^a,b,c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

GIT2; Hepatitis; Innate immunity; Knock out mice; T cell activation

Indexed keywords

ALPHA INTERFERON; CONCANAVALIN A; G PROTEIN COUPLED RECEPTOR KINASE INTERACTOR 2; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; SCAFFOLD PROTEIN; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LIVER FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONCANAVALIN A-INDUCED HEPATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; INFLAMMATORY CELL; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 84955289017     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2015.08.005     Document Type: Article

References (44)

1. Wu Z., Han M., Chen T., Yan W., Ning Q. Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int. 2010, 30:782-794.
2. Dong Z., Wei H., Sun R., Tian Z. The roles of innate immune cells in liver injury and regeneration. Cell. Mol. Immunol. 2007, 4:241-252.
3. Wang H.X., Liu M., Weng S.Y., Li J.J., Xie C., He H.L., Guan W., Yuan Y.S., Gao J. Immune mechanisms of concanavalin A model of autoimmune hepatitis. World J. Gastroenterol. 2012, 18:119-125.
4. Tiegs G., Hentschel J., Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 1992, 90:196-203.
5. Hoefen R.J., Berk B.C. The multifunctional GIT family of proteins. J. Cell Sci. 2006, 119:1469-1475.
6. Premont R.T., Claing A., Vitale N., Perry S.J., Lefkowitz R.J. The GIT family of ADP-ribosylation factor GTPase-activating proteins. Functional diversity of GIT2 through alternative splicing. J. Biol. Chem. 2000, 275:22373-22380.
7. Brown M.C., Cary L.A., Jamieson J.S., Cooper J.A., Turner C.E. Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness. Mol. Biol. Cell 2005, 16:4316-4328.
8. Brown M.C., West K.A., Turner C.E. Paxillin-dependent paxillin kinase linker and p21-activated kinase localization to focal adhesions involves a multistep activation pathway. Mol. Biol. Cell 2002, 13:1550-1565.
9. Ku G.M., Yablonski D., Manser E., Lim L., Weiss A. A PAK1-PIX-PKL complex is activated by the T-cell receptor independent of Nck, Slp-76 and LAT. EMBO J. 2001, 20:457-465.
10. Phee H., Abraham R.T., Weiss A. Dynamic recruitment of PAK1 to the immunological synapse is mediated by PIX independently of SLP-76 and Vav1. Nat. Immunol. 2005, 6:608-617.
11. Gavina M., Za L., Molteni R., Pardi R., de Curtis I. The GIT-PIX complexes regulate the chemotactic response of rat basophilic leukaemia cells. Biol. Cell 2010, 102:231-244.
12. Missy K., Hu B., Schilling K., Harenberg A., Sakk V., Kuchenbecker K., Kutsche K., Fischer K.D. AlphaPIX Rho GTPase guanine nucleotide exchange factor regulates lymphocyte functions and antigen receptor signaling. Mol. Cell. Biol. 2008, 28:3776-3789.
13. Mazaki Y., Hashimoto S., Tsujimura T., Morishige M., Hashimoto A., Aritake K., Yamada A., Nam J.M., Kiyonari H., Nakao K., Sabe H. Neutrophil direction sensing and superoxide production linked by the GTPase-activating protein GIT2. Nat. Immunol. 2006, 7:724-731.
14. Phee H., Dzhagalov I., Mollenauer M., Wang Y., Irvine D.J., Robey E., Weiss A. Regulation of thymocyte positive selection and motility by GIT2. Nat. Immunol. 2010, 11:503-511.
15. Zabaneh D., Balding D.J. A genome-wide association study of the metabolic syndrome in Indian Asian men. PLoS One 2010, 5:e11961.
16. Jiang W., Zheng L., Yang Q., Huang Z., Wang X. Investigation into the effect of hepatitis B virus on apolipoprotein A1 expression and its mechanism. Lipids Health Dis. 2014, 13:130.
17. Gao B., Radaeva S., Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J. Leukoc. Biol. 2009, 86:513-528.
18. Lou Y.F., Dong W., Ye B., Lin S., Mao W.L. Changes in peripheral T-lymphocyte subsets in acute-on-chronic liver failure patients with artificial liver support system. Hepatogastroenterology 2012, 59:814-817.
19. Hussain T., Kulshreshtha K.K., Yadav V.S., Katoch K. CD4+, CD8+, CD3+ cell counts and CD4+/CD8+ ratio among patients with mycobacterial diseases (Leprosy, Tuberculosis), HIV infections and Normal Healthy Adults: a comparative analysis of studies in different regions of India. J. Immunoassay Immunochem. 2014.
20. Adams D.H., Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat. Rev. Immunol. 2006, 6:244-251.
21. Adams D.H., Ju C., Ramaiah S.K., Uetrecht J., Jaeschke H. Mechanisms of immune-mediated liver injury. Toxicol. Sci. 2010, 115:307-321.
22. Lee W.Y., Kubes P. Leukocyte adhesion in the liver: distinct adhesion paradigm from other organs. J. Hepatol. 2008, 48:504-512.
23. Roy-Chaudhury P., Wu B., King G., Campbell M., Macleod A.M., Haites N.E., Simpson J.G., Power D.A. Adhesion molecule interactions in human glomerulonephritis: importance of the tubulointerstitium. Kidney Int. 1996, 49:127-134.
24. Shetty S., Lalor P.F., Adams D.H. Lymphocyte recruitment to the liver: molecular insights into the pathogenesis of liver injury and hepatitis. Toxicology 2008, 254:136-146.
25. Kusters S., Gantner F., Kunstle G., Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996, 111:462-471.
26. Gantner F., Leist M., Lohse A.W., Germann P.G., Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995, 21:190-198.
27. Werlen G., Jacinto E., Xia Y., Karin M. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 1998, 17:3101-3111.
28. Smith-Garvin J.E., Koretzky G.A., Jordan M.S. T cell activation. Annu. Rev. Immunol. 2009, 27:591-619.
29. Leo A., Wienands J., Baier G., Horejsi V., Schraven B. Adapters in lymphocyte signaling. J. Clin. Invest. 2002, 109:301-309.
30. Hobbs J.A., Cho S., Roberts T.J., Sriram V., Zhang J., Xu M., Brutkiewicz R.R. Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus. J. Virol. 2001, 75:10746-10754.
31. Wilson M.T., Johansson C., Olivares-Villagomez D., Singh A.K., Stanic A.K., Wang C.R., Joyce S., Wick M.J., Van Kaer L. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:10913-10918.
32. Zhang L., Zhao Y. The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road. J. Cell. Physiol. 2007, 211:590-597.
33. Okeke E.B., Okwor I., Mou Z., Jia P., Uzonna J.E. CD4+CD25+ regulatory T cells attenuate lipopolysaccharide-induced systemic inflammatory responses and promotes survival in murine Escherichia coli infection. Shock 2013, 40:65-73.
34. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
35. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., Shimizu J., Takahashi T., Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 2006, 212:8-27.
36. Kim J.M., Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol. Rev. 2006, 212:86-98.
37. Akiyama T., Maeda S., Yamane S., Ogino K., Kasai M., Kajiura F., Matsumoto M., Inoue J. Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science 2005, 308:248-251.
38. Kajiura F., Sun S., Nomura T., Izumi K., Ueno T., Bando Y., Kuroda N., Han H., Li Y., Matsushima A., Takahama Y., Sakaguchi S., Mitani T., Matsumoto M. NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner. J. Immunol. 2004, 172:2067-2075.
39. Wei J., Wei C., Wang M., Qiu X., Li Y., Yuan Y., Jin C., Leng L., Wang J., Yang X., He F. The GTPase-activating protein GIT2 protects against colitis by negatively regulating Toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:8883-8888.
40. Kong K.F., Fu G., Zhang Y., Yokosuka T., Casas J., Canonigo-Balancio A.J., Becart S., Kim G., Yates J.R., Kronenberg M., Saito T., Gascoigne N.R., Altman A. Protein kinase C-eta controls CTLA-4-mediated regulatory T cell function. Nat. Immunol. 2014, 15:465-472.
41. Ong C.C., Jubb A.M., Zhou W., Haverty P.M., Harris A.L., Belvin M., Friedman L.S., Koeppen H., Hoeflich K.P. P21-activated kinase 1: PAK'ed with potential. Oncotarget 2011, 2:491-496.
42. Suda Y., Aizawa S., Hirai S., Inoue T., Furuta Y., Suzuki M., Hirohashi S., Ikawa Y. Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice. EMBO J. 1987, 6:4055-4065.
43. Yu M., Wang J., Li W., Yuan Y.Z., Li C.Y., Qian X.H., Xu W.X., Zhan Y.Q., Yang X.M. Proteomic screen defines the hepatocyte nuclear factor 1alpha-binding partners and identifies HMGB1 as a new cofactor of HNF1alpha. Nucleic Acids Res. 2008, 36:1209-1219.
44. McKarns S.C., Schwartz R.H. Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3. J. Immunol. 2005, 174:2071-2083.